- Moderna Stock Volatile Amid Work on Coronavirus Vaccine Yahoo Finance
- Vaccine experts say Moderna’s Covid-19 data leave big questions STAT
- Dow stumbles 390 points lower to end down sharply as report throws cold water on Moderna’s coronavirus vaccine candidate MarketWatch
- Moderna’s claim of favorable results in its vaccine trial is an example of ‘publication by press release’ The Washington Post
- Vaccine Developers Like Moderna Need to Take Their Time Bloomberg
- View Full Coverage on Google News
Source: Google Finance – Market News